Month: May 2024

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference

Written by Customer Service on May 16, 2024. Posted in Public Companies.

Fort Lee, NJ, May 16, 2024 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present at the H.C. Wainwright 2nd BioConnect Investor Conference at the NASDAQ world headquarters in New York City.Event H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQDate May 20th, 2024Time 12:00 PM Eastern TimeLink Fireside Chat [Link]About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment...

May 2024 Letter to Shareholders

Written by Customer Service on May 16, 2024. Posted in Public Companies.

VANCOUVER, Washington, May 16, 2024 (GLOBE NEWSWIRE) — Dear Shareholders, I write today to provide an update on CytoDyn Inc. (“CytoDyn” or “Company”), as we approach the end of our 2024 fiscal year (May 31, 2024), and to sincerely thank you for your unwavering support. Fiscal year 2024 was a significant year for CytoDyn, and one that I believe will be remembered as the beginning of a turnaround. The Company achieved the lifting of the FDA’s clinical hold in late February 2024 and is now working to return to the clinic. Over the past several months, the Company has made significant internal progress on key initiatives which we believe will lead to marked external developments in the form of the commencement of clinical trials, the rollout of a number of pre-clinical research initiatives, and the continued publication of leronlimab...

SHARC Energy Announces Q1 2024 Financial Results

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, May 16, 2024 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) announces it has filed financial results for the three months ended March 31, 2024. All figures are in Canadian Dollars and in accordance with IFRS unless otherwise stated. First Quarter Financial Highlights:As of May 16, 2024, the Company has a Sales Pipeline1 of $17.0 million (M) and Sales Order Backlog2 of $2.3M. Sales Pipeline saw a marginal increase of 1% or $0.1M while revenue recognition improved, drawing down Sales Order Backlog by $0.7M since April 29, 2024 disclosure. The Company has hit an inflection point in the maturity of its Sales Pipeline, giving management confidence that 2024 will be a transformative year for SHARC Energy.Revenue...

Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, May 16, 2024 (GLOBE NEWSWIRE) — IMPERIAL PETROLEUM INC. (NASDAQ: IMPP, the “Company”), a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services, announced today its unaudited financial and operating results for the three months ended March 31, 2024. OPERATIONAL AND FINANCIAL HIGHLIGHTSFleet operational utilization of 80.6% in Q1 24’, an improved performance compared to Q4 23’, mainly due to a 29.3% (65 days) decrease in commercial idle days. In Q1 23’our operational utilization was 85.0%. 75.0% of fleet calendar days, equivalent to 671 days, in Q1 24’ were dedicated to spot activity. Revenues of $41.2 million in Q1 24’, compared to $29.9 million in Q4 23’, equivalent to a 37.8% rise and $65.4 million of revenues in Q1 23’. Net Income of $16.7 million in Q1 24’...

Blockchain as a Service Market to Surpass USD 94.43 Billion by 2031 | SkyQuest Technology

Written by Customer Service on May 16, 2024. Posted in Mergers And Acquisitions.

Westford, USA, May 16, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global Blockchain as a Service Market will attain a value of USD 94.43 Billion by 2031, with a CAGR of 57.10% during the forecast period (2024-2031). Blockchain-as-a-service, or BaaS, refers to the use of third parties to build and manage cloud-based networks for businesses that create blockchain applications. In the quickly developing field of blockchain technology, third-party services are a relatively new concept. Blockchain technology is increasingly being used for safe transactions of many kinds, far beyond its most well-known application in bitcoin transactions. Throughout the projection period, the rise in cyberthreats following the COVID-19 pandemic contributed to the expansion of worldwide blockchain as a service (BaaS) solution. Download a detailed...

Nature’s Miracle and Agrify Corporation Announces Signing of the Definitive Merger Agreement

Written by Customer Service on May 16, 2024. Posted in Mergers And Acquisitions.

Transaction Expected to Close in the Second Half of 2024 ONTARIO, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Nature’s Miracle Holding Inc. (NASDAQ: NMHI; NMHIW) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology and infrastructure, and Agrify Corporation (NASDAQ: AGFY) (“Agrify”), announced today that both parties have signed a definitive agreement and plan of merger (“Agreement”) in which a new wholly-owned subsidiary of Nature’s Miracle will merge with and into Agrify, with Agrify surviving the merger as a wholly-owned subsidiary of Nature’s Miracle. The signing of the definitive agreement directly follows the previously announced term sheet for the merger. The Transaction Agrify shareholders who do not dissent to the merger will each be issued 0.45 of a share of Nature’s Miracle common stock for...

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May 16, at 8:30 AM ET OCALA, Fla., May 16, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported its financial results for the first quarter 2024. As previously announced, the Company will host a conference call and webcast today, Thursday, May 16, 2024, at 8:30 AM ET (details below). “AIM is making fundamental progress across our clinical development programs and continues to be encouraged by Ampligen’s potential. We recently reported encouraging top-line data across our pipeline. We also recently completed cGMP manufacturing of 9,000 vials of Ampligen. Both of these successes are extremely important...

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform

Written by Customer Service on May 16, 2024. Posted in Public Companies.

LAS VEGAS, May 16, 2024 (GLOBE NEWSWIRE) — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence (AI) technology company specializing in the development of advanced AI and data center infrastructure solutions, today announced an ambitious plan to develop a cutting-edge, proprietary AI software platform to power its next-generation data centers. This advanced platform will leverage machine learning algorithms to analyze data, predict resource needs, and make real-time resource allocation decisions, ushering in a new era of intelligent and autonomous data center management. Avant is developing an AI platform specifically designed to address the unique challenges and opportunities of data center management. The platform will be built on proprietary machine-learning algorithms developed in-house....

Q1 2024 results in line with expectations. Full-year guidance narrowed

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Announcement no. 9-2024 16 May 2024 North Media CEO Lasse Ingemann Brodt commented on the results for Q1 2024:“In the first quarter of 2024, with performance in line with expectations, we focused on integrating SDR Svensk Direktreklam in the North Media Group. We have taken the first steps to exploit the potential for mutual development with FK distribution, including the transition to shared use of the Danish production systems and planned testing of automated packaging of printed matter for the Swedish market in Q2 2024. In Digital Services, the results were impacted by increased costs for strategic development of the businesses, which was expected. Based on greater insight into SDR’s business, we are narrowing our full-year guidance.” Guidance for 2024 The Group narrows its revenue and EBITDA guidance. Revenue is now expected to be...

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024

Written by Customer Service on May 16, 2024. Posted in Earnings Releases And Operating Results.

Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., May 16, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the first quarter ended March 31, 2024. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “I am pleased to report our domestic, direct sales strategy within our dental segment has proven effective, as a result of our new online sales portal, which recorded growth of 31% over the same period...

Month: May 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals